What are the dangers of high LDL cholesterol?

High LDL cholesterol significantly increases your risk of heart disease, stroke, and peripheral artery disease by forming dangerous plaques in your arteries. Without symptoms until serious damage occurs, regular testing and proactive management through diet, exercise, and medication when needed are essential for prevention.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding LDL cholesterol and why it matters

Low-density lipoprotein (LDL) cholesterol, often called 'bad cholesterol,' plays a complex role in your body. While you need some cholesterol for essential functions like hormone production and cell membrane formation, too much LDL cholesterol in your bloodstream can lead to serious health complications that develop silently over years or decades.

Unlike many health conditions that announce themselves with obvious symptoms, high LDL cholesterol works quietly in the background, gradually damaging your cardiovascular system. This silent progression makes it particularly dangerous, as many people discover they have high cholesterol only after experiencing a major cardiovascular event or during routine blood work.

How LDL cholesterol affects your arteries

When LDL cholesterol levels remain elevated, excess particles can penetrate the inner lining of your arteries. Once there, they undergo oxidation and trigger an inflammatory response. Your immune system sends white blood cells to clean up the oxidized LDL, but these cells become engorged with cholesterol and transform into foam cells, forming the foundation of arterial plaques.

LDL Cholesterol Levels and Risk Categories

LDL Level (mg/dL)CategoryRisk LevelTypical Action
Less than 100<100 mg/dLOptimalLow riskMaintain healthy lifestyle
100-129100-129 mg/dLNear optimalSlightly elevated riskLifestyle modifications recommended
130-159130-159 mg/dLBorderline highModerate riskAggressive lifestyle changes, consider medication
160-189160-189 mg/dLHighHigh riskMedication often necessary with lifestyle changes
190 and above≥190 mg/dLVery highVery high riskImmediate medication typically required

Target LDL levels may be lower for individuals with diabetes, heart disease, or multiple risk factors.

Over time, these plaques grow larger and harder, narrowing your arteries and reducing blood flow. This process, called atherosclerosis, can affect arteries throughout your body, from those feeding your heart and brain to those supplying your legs and other organs. Understanding your cholesterol levels through regular testing helps you take action before significant damage occurs.

Major health risks of elevated LDL cholesterol

Coronary artery disease and heart attacks

The most well-known danger of high LDL cholesterol is coronary artery disease (CAD), which occurs when plaques build up in the arteries supplying your heart muscle. As these arteries narrow, your heart receives less oxygen-rich blood, potentially causing chest pain (angina) during physical activity or stress.

The real danger comes when a plaque ruptures. This can trigger a blood clot that completely blocks the artery, causing a heart attack. According to the American Heart Association, someone in the United States has a heart attack every 40 seconds, and high LDL cholesterol is a major contributing factor in most cases.

Stroke risk and brain health

High LDL cholesterol doesn't just threaten your heart—it also endangers your brain. When plaques form in the carotid arteries (which supply blood to your brain) or in smaller brain arteries, they can cause ischemic strokes. These strokes occur when blood flow to part of your brain is blocked, leading to brain cell death and potentially permanent disability.

Research published in the journal Stroke found that for every 10 mg/dL increase in LDL cholesterol, stroke risk increases by approximately 2-3%. Additionally, chronic high cholesterol may contribute to vascular dementia by reducing blood flow to brain regions critical for memory and cognitive function.

Peripheral artery disease

When atherosclerosis affects arteries in your legs and arms, it causes peripheral artery disease (PAD). This condition reduces blood flow to your extremities, causing symptoms like leg pain when walking (claudication), slow-healing wounds, and in severe cases, tissue death requiring amputation. People with PAD have a significantly higher risk of heart attack and stroke, as the disease indicates widespread arterial damage.

LDL cholesterol levels: What's considered dangerous?

Understanding what constitutes high LDL cholesterol helps you assess your risk and take appropriate action. The following ranges provide general guidelines, though your target levels may vary based on other risk factors.

Your optimal LDL target depends on your overall cardiovascular risk profile. People with diabetes, existing heart disease, or multiple risk factors often need to maintain LDL levels below 70 mg/dL or even lower. Recent research suggests that when it comes to LDL cholesterol, lower is generally better for cardiovascular protection.

Hidden dangers: Why high LDL is called the 'silent killer'

One of the most insidious aspects of high LDL cholesterol is its lack of symptoms. You can have dangerously high levels for years without feeling anything unusual. This absence of warning signs means that significant arterial damage can accumulate before you're aware of the problem.

Many people discover they have high cholesterol only after experiencing a heart attack or stroke, or during routine blood work for other reasons. This is why regular cholesterol screening is crucial—it's the only way to know your levels and take preventive action before irreversible damage occurs.

The cumulative effect of cholesterol exposure

Research shows that your lifetime exposure to LDL cholesterol matters as much as your current levels. This concept, called 'cholesterol-years,' means that having moderately elevated LDL for decades can be as dangerous as having very high levels for a shorter time. Young adults with even mildly elevated LDL cholesterol face increased cardiovascular risk later in life if levels remain unchecked.

Beyond cardiovascular disease: Other health impacts

While cardiovascular complications dominate discussions about high LDL cholesterol, elevated levels can affect other aspects of your health. Research links high cholesterol to increased risk of gallstones, as excess cholesterol can crystallize in your gallbladder. Some studies also suggest connections between high LDL and certain types of cancer, though more research is needed to establish causation.

High LDL cholesterol often occurs alongside other metabolic issues like insulin resistance, high blood pressure, and abdominal obesity—a cluster of conditions known as metabolic syndrome. This combination multiplies your risk of diabetes and cardiovascular disease, making comprehensive metabolic health monitoring essential.

Testing and monitoring your LDL cholesterol

Given the serious risks associated with high LDL cholesterol and its silent nature, regular testing is your best defense. Traditional lipid panels measure total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. However, advanced testing can provide more detailed insights into your cardiovascular risk.

Advanced cholesterol testing

Beyond standard LDL measurements, tests for apolipoprotein B (ApoB) offer a more accurate assessment of cardiovascular risk. ApoB represents the number of atherogenic particles in your blood, providing better risk prediction than LDL cholesterol alone. Some experts now consider ApoB the superior marker for guiding treatment decisions.

Particle size testing can also provide valuable information, as small, dense LDL particles are more atherogenic than larger, fluffier ones. Additionally, testing for lipoprotein(a), a genetic variant of LDL, helps identify individuals at heightened cardiovascular risk regardless of their standard LDL levels.

Taking action: Managing high LDL cholesterol

If you have high LDL cholesterol, several strategies can help lower your levels and reduce your cardiovascular risk. The approach typically starts with lifestyle modifications, which can significantly impact cholesterol levels for many people.

Dietary changes for cholesterol management

Your diet plays a crucial role in managing LDL cholesterol. Focus on reducing saturated fat intake from sources like red meat and full-fat dairy products, and eliminate trans fats entirely. Instead, emphasize foods rich in soluble fiber, such as oats, beans, and fruits, which help remove cholesterol from your body. Include heart-healthy fats from sources like olive oil, nuts, and fatty fish.

The Mediterranean diet pattern, rich in vegetables, whole grains, lean proteins, and healthy fats, has shown particular effectiveness in improving cholesterol profiles. Plant sterols and stanols, found in fortified foods or supplements, can also help block cholesterol absorption in your intestines.

Exercise and lifestyle factors

Regular physical activity helps lower LDL cholesterol while raising protective HDL cholesterol. Aim for at least 150 minutes of moderate-intensity exercise weekly, combining aerobic activities with strength training. Weight loss, even modest amounts, can improve your cholesterol profile, especially if you carry excess weight around your midsection.

Other lifestyle factors matter too. Quitting smoking improves HDL cholesterol and overall cardiovascular health. Managing stress through techniques like meditation or yoga may help, as chronic stress can negatively impact cholesterol levels. Limiting alcohol intake is also important, as excessive drinking can raise triglycerides and contribute to liver problems.

When medication becomes necessary

For some people, lifestyle changes alone aren't sufficient to reach healthy LDL levels. Statins remain the first-line medication for lowering LDL cholesterol, with extensive research supporting their effectiveness in reducing cardiovascular events. Other options include ezetimibe, which blocks cholesterol absorption, PCSK9 inhibitors for dramatic LDL reduction, and bile acid sequestrants.

The decision to start medication depends on your overall cardiovascular risk, not just your LDL level. Your healthcare provider will consider factors like age, blood pressure, smoking status, and family history when recommending treatment. Regular monitoring ensures your treatment plan remains effective and allows for adjustments as needed.

The importance of early detection and prevention

The dangers of high LDL cholesterol underscore the critical importance of early detection and proactive management. Since arterial damage begins early and accumulates over time, identifying and addressing elevated cholesterol in your 20s and 30s can prevent decades of silent damage. Even if you feel healthy, regular cholesterol screening provides invaluable insight into your cardiovascular risk.

Prevention remains far more effective than treating established cardiovascular disease. By understanding your cholesterol levels, making informed lifestyle choices, and working with healthcare providers when necessary, you can significantly reduce your risk of heart attacks, strokes, and other complications. Remember, when it comes to LDL cholesterol, knowledge truly is power—the power to protect your long-term health and vitality.

References

  1. Ference, B. A., et al. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal, 38(32), 2459-2472.[Link][PubMed][DOI]
  2. Grundy, S. M., et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology, 73(24), e285-e350.[Link][PubMed][DOI]
  3. Silverman, M. G., et al. (2016). Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA, 316(12), 1289-1297.[Link][PubMed][DOI]
  4. Sniderman, A. D., et al. (2019). Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology, 4(12), 1287-1295.[Link][PubMed][DOI]
  5. Domanski, M. J., et al. (2020). Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk. Journal of the American College of Cardiology, 76(13), 1507-1516.[PubMed][DOI]
  6. Mach, F., et al. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1), 111-188.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my LDL cholesterol at home?

You can test your LDL cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing with LDL, HDL, triglycerides, and advanced markers like ApoB. The program provides lab-quality results from a simple at-home blood draw.

At what age should I start checking my cholesterol?

The American Heart Association recommends adults 20 and older have their cholesterol checked every 4-6 years. However, if you have risk factors like family history of heart disease, diabetes, or obesity, you should start earlier and test more frequently. Children with family history of high cholesterol should be tested between ages 9-11.

Can high LDL cholesterol be reversed?

Yes, high LDL cholesterol can often be significantly reduced through lifestyle changes and, when necessary, medication. Diet modifications, regular exercise, and weight loss can lower LDL by 20-30% in many people. However, existing arterial plaques typically don't disappear completely, which is why prevention and early treatment are so important.

What's the difference between LDL and total cholesterol?

Total cholesterol includes all types of cholesterol in your blood: LDL (bad), HDL (good), and VLDL cholesterol. LDL specifically refers to the low-density lipoprotein particles that can build up in arteries. While total cholesterol gives an overview, LDL levels are more important for assessing cardiovascular risk.

How quickly can lifestyle changes lower LDL cholesterol?

You can see improvements in LDL cholesterol within 3-6 weeks of making dietary changes, though maximum benefits typically occur after 3-6 months. Exercise effects may take slightly longer to manifest. The speed and degree of improvement depend on factors like your baseline levels, genetics, and how consistently you follow the changes.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details